A group of bird researchers in Korea has lost their 2006 paper on DNA barcoding of that country’s avian species because they feathered the article with material from others. The paper, “DNA barcoding Korean birds,” appeared in Molecules and Cells, published by Springer for the Korean Society for Molecular and Cellular Biology and has been … Continue reading Clone call for bird gene bar-coding paper
We have an update on the case of Pankaj Dhonukshe, a scientist about whom we reported in November. Utrecht University has found that Dhonukshe, a former researcher at the Dutch university, committed “a violation of academic integrity” in work that led to a number of papers, including one published in Nature and once since retracted … Continue reading Utrecht University finds “violation of academic integrity” by former researcher
A leading chemist at the University of Washington, Larry Dalton, has retracted a 2004 study in Inorganica Chimica Acta, marking his second retraction in the journal in 47 years. Here’s the new notice:
Two major publishers will remove more than 120 papers created with random paper generator SCIgen, according to Nature. Richard van Noorden, who has the scoop, reports:
Yet another busy week at Retraction Watch, with one of us taking part in a symposium on the future of science journalism for a few days. (See if you can find Ivan in this picture.) Here’s what was happening elsewhere on the web in science publishing and related issues:
A pair of researchers at the University of Maryland have retracted a paper in Cell Death & Differentiation after it became clear that one of the figures had been duplicated from an earlier paper. Here’s the notice, dated December 13, 2013, for “INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis,” by Suryakant Niture and … Continue reading Figure duplication kills cell death paper
Woo-Suk Hwang is having quite a comeback. The cloning researcher’s fall from grace in 2005 and 2006 was covered worldwide, featuring two high-profile retractions from Science and convictions (now under appeal) on charges he embezzled government funds and broke South Korea’s bioethics law. But as Nature reported last month in a profile focusing on Hwang’s … Continue reading Fraud, retractions no barrier to US cloning patent for Woo-Suk Hwang
Another busy week at Retraction Watch, featuring lots of snow at HQ and a trip to take part in a conference in Davis, California. Here’s what was happening elsewhere on the web:
Senator Charles Grassley of Iowa — known for his tough questions for the National Institutes of Health (NIH) — wants to know why a former researcher at Iowa State University wasn’t prosecuted more vigorously after he was found to have deliberately spiked rabbit blood samples in a federally-funded HIV vaccine study. As Tony Leys of … Continue reading Should scientific fraud be treated as a crime?
Another busy week at Retraction Watch. Here’s a sampling of items about scientific publishing, research misconduct, and related issues from around the web: